---
layout: minimal-medicine
title: Thiotepa
---

# Thiotepa
### Generic Name
Thiotepa

### Usage
Thiotepa is a chemotherapy drug primarily used to reduce the risk of graft rejection in pediatric patients with class 3 beta-thalassemia undergoing allogeneic hematopoietic stem cell transplantation (HSCT).  It's used in conjunction with high-dose busulfan and cyclophosphamide.  Other uses include treating adenocarcinoma of the breast or ovary, controlling intracavitary effusions from various cancers affecting serosal cavities, and treating superficial papillary carcinoma of the urinary bladder.  It's also used off-label in several other contexts, including treatment of leptomeningeal metastases and in HSCT regimens for central nervous system (CNS) malignancies.  The specific use and dosage will depend heavily on the individual's condition and the physician's assessment.

### Dosage
Thiotepa dosage varies greatly depending on the condition being treated, the route of administration (intravenous (IV), intracavitary, or intrathecal), and the patient's age and weight.  Precise dosing instructions must come from a qualified healthcare professional.  The information below is for illustrative purposes only and should not be interpreted as a prescription or guideline.

**Adult Dosage (Examples; not exhaustive):**

* **Adenocarcinoma of breast or ovary (IV):** 0.3-0.4 mg/kg every 1-4 weeks.  Maintenance dosage is adjusted weekly based on blood counts.
* **Bladder cancer (papillary, intravesical):** 60 mg in 30-60 mL normal saline (NS), retained for 2 hours weekly for 4 weeks.
* **Bone marrow transplant (off-label, IV):** 500 mg/m², with a maximum dose of 1125 mg/m².
* **Malignant effusion (intracavitary):** 0.6-0.8 mg/kg or 30-60 mg weekly.
* **HSCT for CNS malignancy (off-label, IV):**  Various regimens exist, often involving multiple doses over several days before transplantation.

**Pediatric Dosage (Examples; not exhaustive):**

* **Beta-thalassemia (class 3, IV):** 5 mg/kg in two doses 12 hours apart, 6 days before HSCT, in conjunction with other medications.
* **HSCT for CNS malignancy (off-label, IV):** Various regimens exist, often involving multiple doses over several days before transplantation.


### Side Effects
Common side effects include fatigue, nausea, vomiting, loss of appetite, mouth sores (stomatitis), diarrhea, and hair loss (alopecia).  More serious, but less common, side effects include myelosuppression (bone marrow suppression leading to low blood counts), seizures, and hypersensitivity reactions (including anaphylaxis).  Secondary malignancies (like leukemia) are also a potential long-term risk.  Any unexpected or concerning side effect warrants immediate medical attention.

### How it Works
Thiotepa is an alkylating agent. It works by damaging the DNA of rapidly dividing cells, including cancer cells, preventing them from growing and dividing.  This damage primarily occurs through alkylation of guanine in DNA, disrupting its structure and function.


### Precautions
Thiotepa is contraindicated in individuals with hypersensitivity to it or its components and those receiving live or attenuated vaccines concurrently.  It should be used with extreme caution in patients with liver or kidney problems.  The risk of severe myelosuppression is significant, potentially leading to life-threatening infections or bleeding.  Close monitoring of blood counts is essential.  Thiotepa is categorized as a Category D drug during pregnancy, meaning it poses a risk to the fetus. Breastfeeding is not recommended while using Thiotepa.  Interactions with other medications are possible; a healthcare professional should be consulted to assess potential drug interactions.  Concomitant use with other alkylating agents or radiation therapy increases the risk of side effects.

### FAQs
* **Q: How is Thiotepa stored?** A: Storage instructions will vary depending on the formulation, so always follow the directions on the label. Generally, it should be kept at a controlled room temperature, away from light and moisture.
* **Q: How long does it take to work?** A: The therapeutic effect depends on the indication and dosage.  It's not a quick-acting drug; results are generally observed over time with ongoing treatment.
* **Q: What should I do if I miss a dose?** A:  Never adjust the dosage or schedule without consulting your doctor or pharmacist.  Follow their guidance for missed doses.
* **Q: Can I drink alcohol while taking Thiotepa?** A: Alcohol should be avoided while on Thiotepa, as it can exacerbate side effects.
* **Q: Is Thiotepa safe for long-term use?** A: Long-term use carries increased risks, including secondary malignancies. The benefits and risks should be carefully evaluated by a healthcare professional.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for diagnosis, treatment, and any questions regarding medications.  The information provided here may not encompass all possible uses, dosages, side effects, or precautions.
